Drug recall D-0085-2018
Product
Lorazepam Tablets, USP CIV, 0.5 mg, 500-count bottle, Rx Only, Manufactured by: Leading Pharma, LLC Fairfield, NJ 07004 NDC 69315-904-05
Reason for recall
Labeling: Label Error on Declared Strength. Bottle labeled as 0.5 mg tablets contained 1mg tablets of lorazepam
Lots and codes
Lot #E00717
Recall details
- Recalling firm
- Leading Pharma, LLC, Fairfield, NJ
- Quantity
- 2952 500-count bottles
- Distribution
- Nationwide in the USA
- Type
- Voluntary: Firm initiated
- Recall initiated
- September 28, 2017
- Terminated
- September 21, 2020
Related products
- Lorazepam – drug information
- NDC 69315-904 Lorazepam · Lorazepam .5 mg/1 · Leading Pharma, LLC
- NDC 69315-905 Lorazepam · Lorazepam 1 mg/1 · Leading Pharma, LLC
- NDC 69315-906 Lorazepam · Lorazepam 2 mg/1 · Leading Pharma, LLC